Solid Biosciences (SLDB) Return on Capital Employed (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,550.00 |
| Dec 31, 2025 | -1,494.00 |
| Sep 30, 2025 | -1,368.00 |
| Jun 30, 2025 | 724.00 |
| Mar 31, 2025 | 1,614.00 |
| Dec 31, 2024 | -1,986.00 |
| Sep 30, 2024 | -1,203.00 |
| Jun 30, 2024 | 705.00 |
| Mar 31, 2024 | 1,355.00 |
| Dec 31, 2023 | 12.00 |
| Sep 30, 2023 | -823.00 |
| Jun 30, 2023 | -656.00 |
| Mar 31, 2023 | 291.00 |
| Dec 31, 2022 | -284.00 |
| Sep 30, 2022 | -349.00 |
| Jun 30, 2022 | -620.00 |
| Mar 31, 2022 | -745.00 |
| Dec 31, 2021 | -137.00 |
| Sep 30, 2021 | -103.00 |
| Jun 30, 2021 | 730.00 |
| Mar 31, 2021 | 7,047.00 |
| Dec 31, 2020 | 17,963.00 |
| Sep 30, 2020 | -8,395.00 |
| Jun 30, 2020 | -5,155.00 |
| Mar 31, 2020 | -3,218.00 |
| Dec 31, 2019 | -770.00 |
| Sep 30, 2019 | -846.00 |
| Jun 30, 2019 | -2,641.00 |
| Mar 31, 2019 | -2,228.00 |
| Dec 31, 2018 | -1,117.00 |
| Sep 30, 2018 | -790.00 |
| Jun 30, 2018 | 949.00 |